New Rapamycin CEO Hired to Handle Funding, FDA Inflection Points
Xconomy,
San Antonio — Rapamycin Holdings has a new CEO, is raising a $3.5 million Series B round of funding, and plans to submit an…
San Antonio — Rapamycin Holdings has a new CEO, is raising a $3.5 million Series B round of funding, and plans to submit an…
San Antonio — Drugs that can cure a disease inevitably draw the most attention. But San Antonio, TX-based Rapamycin Holdings is…